Tokyo, Aug. 30 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058929) titled 'The prospective and cross-sectional study to detect undiagnosed blood borne viruses (BBV) infections at HIV and STI clinics in Japan' on Aug. 30.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Haruka Uemura, AIDS Clinical Center, National Center for Global Health and Meidicine, Japan institute for Health Security.
Condition:
Condition - HIV, hepatitis B, hepatitis C, hepatatis D
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - To assess the prevalence and incidence of BBV (HIV, HBV, HCV, and HDV) in Japan at high risk of STI infection (HIV-positive MSM, HIV-negative MSM, and female commercial sex workers (CSW) and transgender persons at high risk of STIs).
Basic objectives2 - Others
Intervention:
Interventions/Control_1 - blood draw
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1. ACC or SHC patients those who had their first visit at NCGM in 2017 or later (most of them are MSM).
2. Women and trans gender who see PHC or IDC.
Key exclusion criteria - Persons under 18 years of age. Those who cannot read and write Japanese.
Target Size - 4600
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2024 Year 12 Month 11 Day
Date of IRB - 2024 Year 12 Month 24 Day
Anticipated trial start date - 2025 Year 10 Month 01 Day
Last follow-up date - 2026 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067389
Disclaimer: Curated by HT Syndication.
